Impaired efferocytosis in human chronic granulomatous disease is reversed by pioglitazone treatment

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

MOSBY-ELSEVIER

1. Intramural NIH HHS Funding Source: Medline
2. NHLBI NIH HHS [R01 HL114381, P01 HL034303, HL114381] Funding Source: Medline
3. NIAID NIH HHS [R01 AI058228, AI110408, R01 AI110408, AI058228, R56 AI058228] Funding Source: Medline